Studies from in vitro and preclinical studies have confirmed the importance of Src inhibitor in combination with radiotherapy and proton therapy for GBM, reporting that Src inhibition enhances the radiotherapy and proton therapy efficacy against GBM.27–29. This evidence concerns the gene SRC and glioblastoma.